GSK
GSK plc
NYSE · Healthcare · Drug Manufacturers - General · GB
$49.89
−1.93%Margins
Gross margin
72.7%
EBITDA margin
32.7%
EBIT margin
20.7%
Net margin
14.5%
FCF margin
21.0%
27.5%
Return on equity
7.9%
Return on assets
19.3%
Return on invested capital
0.46x
Asset turnover
$11.8B
Cash from operations
$2.08
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026